Avidity Biosciences Inc — Cash Flow (NASDAQ:RNA) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Cash from operating activities -37.12 M-94.81 M-136.27 M-119.06 M-300.87 M-650.44 M -650.44 M Cash from investing activities -7.79 M-82.52 M-189.96 M-130.07 M-854.2 M-38.03 M -38.03 M Cash from financing activities 272.04 M176.32 M346.17 M93.86 M1.19 B850.99 M 850.99 M Free cash flow -38.21 M-98.55 M-139.09 M-123.29 M-307.94 M-663.76 M -663.76 M

Nouvelles

Morning News Wrap-Up 2/27/26: Today’s Biggest Stock Market Stories! - TipRanks.com

Le BPA de Avidity Bio a manqué les attentes de 0,30$, le CA en dessous des prévisions

Avidity Bio earnings missed by $0.30, revenue fell short of estimates

Avidity reporte l’assemblée des actionnaires, fixe les dates de fusion

Avidity postpones stockholder meeting, sets merger dates

BB Biotech 2025 : bénéfice en hausse de 660%, prudence pour 2026

Le médicament d’Avidity contre la dystrophie myotonique montre des résultats prometteurs

Avidity’s myotonic dystrophy drug shows promising results in trial

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

Vaccine Makers Curtail Research and Cut Jobs

U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

F.D.A. Refuses to Review Moderna Flu Vaccine